Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133616) titled 'Effect of HMB enhanced oral nutritional supplements in post-discharge patients after gastrointestinal cancer surgery' on Sept. 29.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Zhongshan Hospital, Fudan University
Condition:
malnutrition
Intervention:
HMB group:N/A
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: HMB group:289;Control group:290;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=334875
Published by HT Digital Content Services with permission from...